Company intelligence / Profile preview

Thinco

Ownership: Private
Development stage: Other

Overview

Thinco offers ARTG-listed diet capsules and drops made in Australia for weight loss. Their products are designed to be used alongside a meal plan and light exercise. They claim average results of up to 7kg lost on the 25-day program or up to 15kg on the 50-day program. Products are manufactured in licensed facilities under Australian pharmaceutical standards but are classified as therapeutic strength nutraceuticals rather than prescription drugs[1][3].

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Small moleculeHerbal extractAmino acid supplementNutraceutical product
Industry: Food & Nutrition

Beyond the preview

Go deeper on Thinco.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thinco.

Explore the full profile